Alterity Therapeutics Limited (ATHE) Social Stream



Alterity Therapeutics Limited (ATHE): $1.95

0.05 (-2.50%)

POWR Rating

Component Grades

Momentum

D

Stability

D

Sentiment

Quality

D

Add ATHE to Watchlist
Sign Up

Industry: Biotech

Industry

NR

Ranked

#263 of 485

in industry

ALTERITY THERAPEUTICS LTD (ATHE) Price Targets From Analysts

Use the tables below to see what analysts covering ALTERITY THERAPEUTICS LTD think about its future price and what recommendations they have for investors and traders.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-08-20 1 $4 $4 $4 $1.89 111.64%
2022-04-14 1 $4.001 $4.001 $4.001 $1.89 111.69%
2022-06-23 2 $4.001 $3 $3.5 $1.89 85.19%
2022-08-03 3 $4.001 $2 $3 $1.89 58.73%
2022-11-22 2 $40.01 $20 $30.003 $1.89 1487.46%
2023-06-05 2 $10 $10 $10 $1.89 429.1%

The Trend in the Analyst Price Target


Over the past 28 weeks, ATHE's average price target has gone up $17.

ATHE reports an average of 417.24% for its upside potential over the past 0 secs.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2023-06-05 1 30 10 20 2.9 589.66%
2023-06-05 1 10 10 10 2.9 244.83%
2023-06-05 2 10 10 10 2.9 244.83%
2023-06-05 2 30 10 20 2.9 589.66%

ATHE Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
2 1 0 1 0 0 2

The Trend in the Broker Recommendations


ATHE's average broker recommendation rating improved by 1 over the prior 52 weeks.

The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for ATHE as an investment opportunity.

  • ALTERITY THERAPEUTICS LTD's number of analysts covering the stock is greater than 24.27% of all US stocks.
  • In terms of how ALTERITY THERAPEUTICS LTD fares relative to all US stocks, note that its average analyst price target is higher than 124% of that group.
  • In terms of how ALTERITY THERAPEUTICS LTD fares relative to stocks in the small market cap category, note that its variance in analysts' estimates is lower than -281.48% of that group.
  • ALTERITY THERAPEUTICS LTD's upside potential (average analyst target price relative to current price) is greater than 696.26% of stocks in the small market cap category.

In the Pharmaceutical Products industry, VRNA, URGN, and VBIV are the three stocks most similar to ALTERITY THERAPEUTICS LTD regarding the price target and analyst recommendation information presented here.

Make investment decisions regarding ATHE using the data that counts. Try POWR Ratings for free.


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!